Literature DB >> 17623349

A new proposal for multivariable modelling of time-varying effects in survival data based on fractional polynomial time-transformation.

Willi Sauerbrei1, Patrick Royston, Maxime Look.   

Abstract

The Cox proportional hazards model has become the standard for the analysis of survival time data in cancer and other chronic diseases. In most studies, proportional hazards (PH) are assumed for covariate effects. With long-term follow-up, the PH assumption may be violated, leading to poor model fit. To accommodate non-PH effects, we introduce a new procedure, MFPT, an extension of the multivariable fractional polynomial (MFP) approach, to do the following: (1) select influential variables; (2) determine a sensible dose-response function for continuous variables; (3) investigate time-varying effects; (4) model such time-varying effects on a continuous scale. Assuming PH initially, we start with a detailed model-building step, including a search for possible non-linear functions for continuous covariates. Sometimes a variable with a strong short-term effect may appear weak or non-influential if 'averaged' over time under the PH assumption. To protect against omitting such variables, we repeat the analysis over a restricted time-interval. Any additional prognostic variables identified by this second analysis are added to create our final time-fixed multivariable model. Using a forward-selection algorithm we search for possible improvements in fit by adding time-varying covariates. The first part to create a final time-fixed model does not require the use of MFP. A model may be given from 'outside' or a different strategy may be preferred for this part. This broadens the scope of the time-varying part. To motivate and illustrate the methodology, we create prognostic models from a large database of patients with primary breast cancer. Non-linear time-fixed effects are found for progesterone receptor status and number of positive lymph nodes. Highly statistically significant time-varying effects are present for progesterone receptor status and tumour size.

Entities:  

Mesh:

Year:  2007        PMID: 17623349     DOI: 10.1002/bimj.200610328

Source DB:  PubMed          Journal:  Biom J        ISSN: 0323-3847            Impact factor:   2.207


  33 in total

1.  Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  BMC Med       Date:  2012-05-29       Impact factor: 8.775

2.  Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  PLoS Med       Date:  2012-05-29       Impact factor: 11.069

3.  Model-based estimation of the attributable fraction for cross-sectional, case-control and cohort studies using the R package AF.

Authors:  Elisabeth Dahlqwist; Johan Zetterqvist; Yudi Pawitan; Arvid Sjölander
Journal:  Eur J Epidemiol       Date:  2016-03-18       Impact factor: 8.082

4.  Regression standardization with the R package stdReg.

Authors:  Arvid Sjölander
Journal:  Eur J Epidemiol       Date:  2016-05-14       Impact factor: 8.082

5.  Cox proportional hazards models with left truncation and time-varying coefficient: Application of age at event as outcome in cohort studies.

Authors:  Minjin Kim; Myunghee Cho Paik; Jiyeong Jang; Ying K Cheung; Joshua Willey; Mitchell S V Elkind; Ralph L Sacco
Journal:  Biom J       Date:  2017-02-03       Impact factor: 2.207

Review 6.  A comparison of statistical methods to predict the residual lifetime risk.

Authors:  Sarah C Conner; Alexa Beiser; Emelia J Benjamin; Michael P LaValley; Martin G Larson; Ludovic Trinquart
Journal:  Eur J Epidemiol       Date:  2022-01-03       Impact factor: 8.082

7.  Flexible modeling improves assessment of prognostic value of C-reactive protein in advanced non-small cell lung cancer.

Authors:  B Gagnon; M Abrahamowicz; Y Xiao; M-E Beauchamp; N MacDonald; G Kasymjanova; H Kreisman; D Small
Journal:  Br J Cancer       Date:  2010-03-16       Impact factor: 7.640

8.  Variables with time-varying effects and the Cox model: some statistical concepts illustrated with a prognostic factor study in breast cancer.

Authors:  Carine A Bellera; Gaëtan MacGrogan; Marc Debled; Christine Tunon de Lara; Véronique Brouste; Simone Mathoulin-Pélissier
Journal:  BMC Med Res Methodol       Date:  2010-03-16       Impact factor: 4.615

9.  Time-varying effects of prognostic factors associated with disease-free survival in breast cancer.

Authors:  Loki Natarajan; Minya Pu; Barbara A Parker; Cynthia A Thomson; Bette J Caan; Shirley W Flatt; Lisa Madlensky; Richard A Hajek; Wael K Al-Delaimy; Nazmus Saquib; Ellen B Gold; John P Pierce
Journal:  Am J Epidemiol       Date:  2009-04-29       Impact factor: 4.897

10.  An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.

Authors:  Kate E Oliver; William E Brady; Michael Birrer; David M Gershenson; Gini Fleming; Larry J Copeland; Krishnansu Tewari; Peter A Argenta; Robert S Mannel; Angeles Alvarez Secord; Jean-Marie Stephan; David G Mutch; Frederick B Stehman; Franco M Muggia; Peter G Rose; Deborah K Armstrong; Michael A Bookman; Robert A Burger; John H Farley
Journal:  Gynecol Oncol       Date:  2017-08-12       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.